Product Information
DULOXETINE HCL DR 40 MG CAP is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $1.3767 per EA under NDC 82009017230. Its NADAC has been published 46 times since Oct 8, 2025.
FDA first approved this application on Jan 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009017230
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208706FDA Approved
1/6/2017
TE Code
AB
On Market Since
7/1/2025
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 40 MG CAP has been published 46 times since Oct 8, 2025, and over the history we have for it it has risen 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3767 per EA |
|---|---|
| All-time high | $1.3767 (Aug 19, 2026) |
| All-time low | $1.0466 (Apr 22, 2026) |
| 52-week high | $1.3767 |
| 52-week low | $1.0466 |
| Median price | $1.1493 |
| Average price | $1.1523 |
| Largest weekly change | +9.9% (Aug 19, 2026) |
| Weeks tracked | 46 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 40 MG CAP, manufactured by Quallent Pharmaceuticals Health LLC, is $1.3767 per EA (NDC 82009017230), effective Aug 19, 2026.
How has the price of DULOXETINE HCL DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 40 MG CAP has risen 5.8%. It has been tracked across 46 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 40 MG CAP?
Since Oct 8, 2025, the NADAC for DULOXETINE HCL DR 40 MG CAP has ranged from a low of $1.0466 (Apr 22, 2026) to a high of $1.3767 (Aug 19, 2026), with a median of $1.1493 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 40 MG CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 40 MG CAP?
DULOXETINE HCL DR 40 MG CAP (NDC 82009017230) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.